12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Cadence, Incline Therapeutics, Medicines Co. deal

The Medicines Co. will acquire Incline for $185 million up front plus up to $205 million in milestones. The Medicines Co. will gain exclusive, worldwide rights to Ionsys fentanyl, which Incline licensed from the Alza Corp. subsidiary of Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J.) in 2010. The transdermal fentanyl patch was marketed in the EU for short-term management...

Read the full 301 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >